Fineotex Chemical · NSE: FCL · BSE: 533333

Q4 FY26 results · Jan–Mar 2026

Fineotex Chemical reported revenue from operations of ₹313.73 crore (up 161.9% from Q4 FY25) and net profit of ₹43.79 crore (up 117.5% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations313.73119.79+161.9%183.71+70.8%
Other income9.467.55+25.3%6.75+40.1%
Total income323.19127.33+153.8%190.46+69.7%
Profit before tax48.1226.42+82.1%38.02+26.6%
Net profit for the period43.7920.13+117.5%30.12+45.4%
Attributable to shareholders of the company31.6119.97+58.3%26.35+20.0%
EPS, basic (₹)0.381.76not comparable0.26+46.2%
Net margin (%)14.016.816.4
Standalone · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations97.60107.95−9.6%96.47+1.2%
Other income7.417.65−3.1%11.28−34.3%
Total income105.01115.60−9.2%107.75−2.5%
Profit before tax24.3625.73−5.3%30.93−21.2%
Net profit for the period21.1419.44+8.7%25.65−17.6%
EPS, basic (₹)0.181.71not comparable0.22−18.2%
Net margin (%)21.718.026.6
Consolidated
Filed with BSE
15 May 2026, 22:59 IST
Board meeting
15 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
15 May 2026, 22:59 IST
Board meeting
15 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE